1Department of Neurological Surgery, University of California, San Francisco, California.
2School of Medicine, Texas Christian University, Fort Worth, Texas.
J Neurosurg. 2022 Nov 4;139(1):11-19. doi: 10.3171/2022.9.JNS221139. Print 2023 Jul 1.
A cancer diagnosis is life altering and frequently associated with both acute and long-lasting psychosocial and behavioral distress for patients. The impact of a diffuse glioma diagnosis on mental health is an important aspect of the patient experience with their disease. This needs to be understood by neurosurgeons so these concerns can be appropriately addressed in a timely fashion and integrated into the multidisciplinary care of neuro-oncology patients. The relatively grave prognosis associated with diffuse gliomas, the morbidity associated with treatment, and the constant threat of developing a new neurological deficit all can negatively affect a patient's mental ability to cope and ultimately manifest in mental health disorders such as anxiety and depression. The objective of this systematic review was to describe the variety of behavioral health disorders patients may experience following a glioma diagnosis and discuss possible treatment options. The PubMed, Web of Science, Embase, and PsycINFO databases were searched through July 1, 2022, using broad search terms, which resulted in 5028 studies that were uploaded to Covidence systematic review software. Duplicates, non-English-language studies, and studies with irrelevant outcomes or incorrect design were removed (n = 3167). A total of 92 articles reporting behavioral health outcomes in brain tumor patients were categorized and extracted for associations with overall mental health, anxiety, depression, distress, stress, pharmacology, interventions, and mental health in caregivers. The authors identified numerous studies reporting the prevalence of mental health disorders and their negative influence in this population. However, there is a paucity of literature on therapeutic options for patients. Given the strong correlation between patient quality of life and mental well-being, there is a considerable need for early recognition and treatment of these behavioral health disorders to optimize everyday functioning for patients.
癌症诊断会改变生活,并且经常会给患者带来急性和长期的心理社会和行为困扰。弥漫性神经胶质瘤诊断对心理健康的影响是患者疾病体验的一个重要方面。神经外科医生需要了解这一点,以便及时解决这些问题,并将其纳入神经肿瘤学患者的多学科治疗中。弥漫性神经胶质瘤相关的预后相对较差、治疗相关的发病率以及不断出现新的神经功能缺损的威胁,所有这些都会对患者的心理应对能力产生负面影响,并最终表现为焦虑和抑郁等心理健康障碍。本系统评价的目的是描述患者在诊断为神经胶质瘤后可能经历的各种行为健康障碍,并讨论可能的治疗选择。通过广泛的搜索词,于 2022 年 7 月 1 日之前在 PubMed、Web of Science、Embase 和 PsycINFO 数据库中进行了搜索,结果有 5028 项研究被上传到 Covidence 系统评价软件。去除了重复的、非英语的研究以及结果或设计不相关的研究(n = 3167)。共有 92 篇报告脑肿瘤患者行为健康结果的文章被分类并提取,以确定与整体心理健康、焦虑、抑郁、痛苦、压力、药理学、干预措施以及照顾者心理健康相关的因素。作者确定了许多研究报告了该人群中精神健康障碍的流行率及其负面影响。然而,针对患者的治疗选择的文献却很少。鉴于患者生活质量和心理健康之间存在很强的相关性,因此需要早期识别和治疗这些行为健康障碍,以优化患者的日常功能。